251
Participants
Start Date
January 18, 2010
Primary Completion Date
May 16, 2013
Study Completion Date
May 16, 2013
13vPnC
"0.5mL 13vPnC dose will be administered intramuscularly into the left limb at visits 1,2,3 and 5.~Starting 3-6 months after HSCT 3 doses given at monthly intervals. 4th dose given 6 months after 3rd dose."
23vPS
0.5mL dose of 23vPS will be administered intramuscularly at visit 6. 23vPS given 1 month after 4th dose of 13vPnC.
Clinical University St Luc, Brussels
Universitaire Ziekenhuizen Leuven (UZ) Gasthuisberg, Leuven
CHU Liege, Liège
Algemeen Ziekenhuis St.-Jan A.V., Bruges
Universitair Ziekenhuis Gent, Belgium
Columbia University Medical Center Research Pharmacy, New York
Columbia University Medical Center-Presbyterian Hospital Building, New York
Columbia University/Taub Institute Irving Center for Clinical Research, New York
New York-Presbyterian Morgan Stanley Children's Hospital, New York
Memorial Sloan Kettering Cancer Center, New York
Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
Charite Universitaetsmedizin, Berlin
Fakultni nemocnice v Motole, Prague
The Children's Hospital of Philadelphia, Philadelphia
Clinical Trial Center North MediGate GmbH, Hamburg
Klinik und Poliklinik fuer Paediatrische Haematologie und Onkologie, Hamburg
Universitaetsklinikum Hamburg Eppendorf Clinical Trial Center North MediGate GmbH, Hamburg
Universitaetsklinikum Hamburg-Eppendorf, Onkologisches Zentrum, Hamburg
Hôpital Jean Minjoz, Besançon
Hospital Universitario La Princesa, Madrid
Hospital Universitario Infantil Niño Jesús, Madrid
Hospital Universitario de Salamanca, Salamanca
University of Kentucky, Lexington
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
"Universitaetsklinikum Muenster,", Münster
Universitaetsklinikum Muenster, Münster
Hôpital Saint Louis, Paris
CHRU Robert Debré, Paris
Hopital Robert Debre, Paris
Hopital Saint-Louis, Paris
Hopital Robert Debre - Service Pharmacie, Paris
Texas Children's Hospital, Houston
Hopital Henri Mondor, Créteil
Hôpital Henri Mondor, Pharmacie, Créteil
CancerCare Manitoba, Winnipeg
Hopital Maisonneuve-Rosemont, Montreal
Fakultni nemocnice Brno/Interni hematoonkologicka klinika, Bmo
Universitatsklinikum Jena, Jena
UMC Utrecht, Wilhelmina Kinder Ziekenhuis, Utrecht
Klinika Hematologii i Transplantologii, Gdansk
"NZOZ HIPOKRATES-II Sp. z o.o.", Krakow
Klinika Transplantacji Szpiku, Onkologii i Hematologii Dzieciecej, Wroclaw
Sahlgrenska Universitetssjukhuset, Gothenburg
Karolinska Universitetssjukhuset Huddinge, Huddinge
Karolinska University Hospital Huddinge, Stockholm
Universitetssjukhuset i Lund, Barnonkologen Avd 64, Lund
Akademiska Sjukhuset, Infektionskliniken, Uppsala
Lead Sponsor
Pfizer
INDUSTRY